Personalized brain therapy hits 68 percent remission for PTSD — 2026-11-05
From Impact Vector: Good News · 2:35
Show by Alutus LLC
## Short Segments At Erik's Ranch in Montana, autistic individuals are taking on roles as wranglers and guides, offering a unique retreat experience. Located near Yellowstone National Park, Erik's Ranch & Retreats employs autistic individuals as concierges, guides, and more, providing them with meaningful work and a supportive community. Founded by Kathryn Nordberg, the ranch was inspired by her son Erik, who is on the autism spectrum. Visitors can enjoy activities like horseback riding and nature hikes, often led by the neurodivergent staff who live on the property. This initiative not only provides employment opportunities but also fosters independence and community for its members. By integrating work and living spaces, Erik's Ranch offers a model for inclusive employment and community living for autistic individuals. ## Feature Story A new personalized brain therapy for PTSD has achieved a 68 percent remission rate in clinical trials, offering a significant improvement over existing treatments. Developed by Wave Neuroscience in collaboration with Texas A&M Health Institute, Magnetic e-Resonance Therapy, or MeRT, uses brain activity mapping and personalized magnetic stimulation to treat PTSD. In trials, MeRT not only achieved a 68 percent remission rate but also reduced PTSD symptoms by 52 percent overall. These results are particularly notable when compared to the best-performing medications, which have a remission rate of around 10.9 percent. The treatment begins with an electroencephalogram (EEG) to record the patient's brain activity. An AI-assisted algorithm then creates a personalized stimulation plan, which is delivered through transcranial magnetic stimulation (TMS). TMS is already FDA-cleared for treatment-resistant depression, adding credibility to its use in PTSD treatment. Dr. Erik Won, chief medical officer at Wave Neuroscience, emphasized the clinical significance of these findings, highlighting the potential for MeRT to transform PTSD care. While the results are promising, it's important to note that these findings come from different studies and not direct comparisons. However, the substantial improvement in remission rates suggests a meaningful advancement in PTSD treatment options. As the therapy gains FDA clearance, it opens new avenues for personalized mental health treatments, potentially benefiting a wide range of patients. Looking ahead, the focus will be on further validating these results and exploring the broader applications of MeRT in mental health care. With its innovative approach, MeRT represents a significant step forward in the treatment of PTSD, offering hope to those affected by this challenging condition.
More episodes of Impact Vector: Good News
More episodes
- ‘Digital advances are reshaping nature conservation’ say experts — 2026-11-09
- Solar kits are changing what disaster relief looks like — 2026-11-06
- Stanford scientists discovered bleached coral can heal through touch — 2026-11-04
- What if we stop treating social care like a service — 2026-11-03
- The women’s boxing nights helping abuse survivors — 2026-11-02
- How EV fleets are shielding Europe from oil price volatility — 2026-10-30
- Kenya unlocks $160 million to protect the Maasai Mara and Tsavo ecosystems — 2026-10-29
- Student Makers, a deeper dive: bringing free STEM to students on three continents — 2026-10-28
- New Jersey Transit is turning commuter stations into art galleries — 2026-10-27
- Free tool helps young men to take responsibility for sexual harm — 2026-10-26
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.